Articles

Polymorphism of the complement receptor 1 gene correlates with the hematologic response to eculizumab in patients with paroxysmal nocturnal hemoglobinuria

Cancer Genetics and Gene Transfer - Core Research Laboratory, Istituto Toscano Tumori, Firenze, Italy
Hematology, Department of Clinical Medicine and Surgery, Federico II University, Napoli, Italy
Service d’Hématologie-Greffe, Hôpital Saint-Louis, Paris, France
Cancer Genetics and Gene Transfer - Core Research Laboratory, Istituto Toscano Tumori, Firenze, Italy
Cancer Genetics and Gene Transfer - Core Research Laboratory, Istituto Toscano Tumori, Firenze, Italy
Hematology, Department of Clinical Medicine and Surgery, Federico II University, Napoli, Italy
Hematology 2, Fondazione IRCCS Cà Granda, Ospedale Maggiore Policlinico, Milano, Italy
Department of Cellular Biotechnologies and Hematology, Sapienza University, Roma, Italy
Hematology 2, Fondazione IRCCS Cà Granda, Ospedale Maggiore Policlinico, Milano, Italy
Department of Cellular Biotechnologies and Hematology, Sapienza University, Roma, Italy
Hôpital Européen Georges Pompidou, Paris, France
Cancer Genetics and Gene Transfer - Core Research Laboratory, Istituto Toscano Tumori, Firenze, Italy;ICCOM - National Council of Research of Italy, Sesto Fiorentino, Italy
Service d’Hématologie-Greffe, Hôpital Saint-Louis, Paris, France;INSERM U728, Institut Universitaire d’Hématologie, Paris, France
Istituto Toscano Tumori, Firenze, Italy
Cancer Genetics and Gene Transfer - Core Research Laboratory, Istituto Toscano Tumori, Firenze, Italy
Vol. 99 No. 2 (2014): February, 2014 https://doi.org/10.3324/haematol.2013.090001